Skip to Content
Get key facts and figures about chronic dry eye

OnabotulinumtoxinA Pregnancy and Breastfeeding Warnings

OnabotulinumtoxinA is also known as: Botox, Botox Cosmetic

OnabotulinumtoxinA Pregnancy Warnings

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus.

US FDA pregnancy category: C

See references

OnabotulinumtoxinA Breastfeeding Warnings

The manufacturer recommends that caution be used when administering onabotulinumtoxinA to nursing women.

Excreted into human milk: Unknown
Excreted into animal milk: Unknown

The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Botox (onabotulinumtoxin A)." Allergan Inc, Irvine, CA.

References for breastfeeding information

  1. "Product Information. Botox (onabotulinumtoxin A)." Allergan Inc, Irvine, CA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide